Clin2
NCT07730138Possibly a fitNot yet recruiting

Treatment for stomach ulcers

Gastric Ulcer

Treatments studied

Part of Digestive system clinical trials.

This study tests a new medicine to help heal stomach ulcers. It may be an option if you have a stomach ulcer that is not too large and is at a certain stage of healing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
384 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You have at least one stomach ulcer that is between 3 and 30 millimeters wide.
  • The largest ulcer is at a stage called A1 or A2, which means it is active and has not started healing yet.
  • You do not have other serious stomach or intestinal conditions, like bleeding, narrowing, or a history of certain cancers.
  • You have not had major surgery in the last 30 days that could affect stomach acid.
  • You do not have a history of Zollinger-Ellison syndrome, which causes too much stomach acid.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07312370Not yet recruiting· Phase 4
Medication after stomach cancer removal for ulcer healing

This study tests whether adding sucralfate (a stomach-lining protectant) to the standard acid-reducer esomeprazole helps heal ulcers that form after a procedure called ESD for early stomach cancer. It helps find which combination works better for recovery.

Lanzhou, Gansu
NCT07708545Recruiting· Phase 2
Comparing two drugs for bleeding ulcers

This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.

Tangerang, Banten
NCT06894992Recruiting
Tegoprazan vs Lansoprazole for Bleeding Peptic Ulcer

This trial compares two acid-reducing medicines—Tegoprazan and Lansoprazole—to see which works better for stopping bleeding from a peptic ulcer. If you have a confirmed upper GI bleed from an ulcer, this study may help find the best treatment for you.

Jakarta, DKI Jakarta
NCT07533266Not yet recruiting· Phase 4
Preventing stomach ulcers from NSAID pain relievers

This trial tests a new medicine, fexuprazan, to see if it can prevent stomach ulcers caused by taking NSAID pain relievers for a long time. If you need daily NSAIDs for arthritis or other muscle/bone pain, this medicine might help protect your stomach.

Seoul
NCT06284876Recruiting· Phase 3
Testing Ilaprazole for Preventing NSAID-Related Stomach Ulcers

This study tests a new medicine called Ilaprazole 10 mg to see if it can prevent stomach ulcers caused by NSAIDs (pain relievers like ibuprofen). If you take NSAIDs regularly and have a higher risk of ulcers, this trial may help protect your stomach.

Seoul
NCT06526455Not yet recruiting· Phase 4
Comparing two acid reducers for healing stomach ulcers after ESD

This trial compares two medicines that reduce stomach acid to help heal ulcers that form after a procedure called ESD, which removes abnormal stomach tissue. The goal is to see if one medicine works better and has fewer side effects.

Guangzhou, Guangdong

Hear when a new Gastric Ulcer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.